A new AI application that can analyse imaging data and alert physicians of a potential stroke in patients has received approval from the U.S. Food and Drug Administration (FDA). The Viz.AI Contact app uses an AI algorithm to analyse computed tomography (CT) scans and identify signs of a stroke in patients.
When the app identifies a potential blockage in the brain, it will notify a neurovascular specialist via smartphone or tablet, reducing the time to treatment.
“Strokes can cause serious and irreversible damage to patients. The software device could benefit patients by notifying a specialist earlier thereby decreasing the time to treatment. Faster treatment may lessen the extent or progression of a stroke,” said Robert Ochs, PhD, acting deputy director for radiological health, Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health.Source: Click here